AUTHOR: Jodi

Aclarion Announces Statistically Significant Nociscan® Cost-Effectiveness Abstract

Nociscan cost-effectiveness abstract highlights dominance over provocative discography and can save the US healthcare system $283M to $441M annually. The International Society for the Advancement of Spine Surgery (ISASS) Annual Meeting was held June 1-3, 2023. ISASS Policy Statement on Lumbar Spinal Fusion Surgery acknowledges MR Spectroscopy as an effective alternative to provocative discography. Broomfield, CO […]

Aclarion Announces New Engagement with The London Clinic and London Spine Clinic

The London Clinic is the UK’s most renowned independent, private hospital, established 1932. The London Spine Clinic is first specialist spinal unit established in England, 1997. The London Clinic will be Aclarion’s first customer in London.   Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and […]

Aclarion’s Key Opinion Leader Program Adds Ninth Surgeon Advisor with Addition of Dean Karahalios, MD

Development of this program supports Aclarion’s commitment to lead with strong clinical evidence and engage the payer community through key opinion leader advocacy. Aclarion to participate in upcoming ISASS 2023 on  June 1-3, 2023 in San Francisco, CA where their health economics outcomes abstract will presented   Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, […]

Aclarion Appoints Nicholas Theodore, MD as Principal Investigator for CLARITY Post-Market Trial

Nicholas Theodore, MD, FACS, FAANS, is Director of Neurosurgical Spine Center, Johns Hopkins, and Professor of Neurosurgery, Orthopaedics and Biomedical Engineering CLARITY is a post-market, multi-site trial, that will further evaluate the role of Nociscan in the diagnosis and surgical treatment of chronic low back pain. CLARITY is targeted to begin in the second half […]

Aclarion Announces Publication of 2YR Outcomes in Groundbreaking Clinical Trial

  Success rate at 2 years for discogenic low back pain surgeries was 85% for patients whose treatment strategy was consistent with Nociscan-identified discs, a 22 percentage point improvement over patients whose treatment strategy was inconsistent with Nociscan-identified discs (85% vs. 63%; p=0.07) Nociscan is the first augmented intelligence platform to measure pain biomarkers in […]

Aclarion Announces Alpesh Patel MD MBA as a Key Opinion Leader Physician Advisor

Marks the eighth advisor to growing KOL program to build strong body of clinical evidence and support US commercialization Aclarion to participate in upcoming SPINEWEEK 2023   Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location […]

Aclarion Supports Thought Leadership at the 2nd Annual Sonntag Spine Symposium

NociscanTM is the first evidence-supported SaaS platform to objectively measure discogenic biomarkers for insight into pathological pain. Nociscan provides decision support to help bridge a major diagnostic void. Robert Eastlack, MD will speak to his real-world experience using Nociscan to effectively evaluate CLBP.   Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare […]

Gregory Basil MD to Join Aclarion as a Key Opinion Leader Surgeon Advisor

Director of Endoscopic Spine Surgery at the University of Miami Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain, announced today that Gregory Basil, MD, Director of Endoscopic Spine Surgery at […]

Aclarion Appoints George Frey MD as Seventh Key Opinion Leader Surgeon Advisor

Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain, announced today that George Frey MD, Founder of the Colorado Comprehensive Spine Institute will advise the company as a key opinion leader […]

Request Info or Schedule a Demo

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Aclarion
8181 Arista Place,
Suite 100
Broomfield, CO 80021

info@aclarion.com

833-ASK-ACON (833-275-2266)

GD USA 2023 Award
GD USA Health & Wellness 2023 Award